Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lingjing Capsules
- Development stage
- Unknown
- Lead developer
- Jiangsu Tiansheng Pharmaceutical
- Administration
- Oral
01
Overview
Lingjing Capsules (灵精胶囊) is a traditional Chinese medicine (TCM) product developed and manufactured by Jiangsu Tiansheng Pharmaceutical. It is formulated as a health supplement primarily composed of extracts from *Ganoderma lucidum* (Lingzhi) and *Panax ginseng* (Ginseng). The product is designed to function as a general health tonic, with primary indications for enhancing the immune system and relieving physical fatigue. It is approved in China and is typically marketed as a "health food" (Blue Hat) product. The capsules are administered orally and are intended to replenish vital energy (Qi) and essence (Jing) according to TCM principles.
- Brand names
- Lingjing
- Other names
- 灵精胶囊
02
Targets
NF-κBSTING (Stimulator of interferon genes protein)TBK1 (TANK binding kinase 1)
Beyond the preview
Go deeper on Lingjing Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lingjing Capsules.